Rapport Therapeutics
Developing recision medicines to match the complexity of the human brain. Learn more
Launch date
Employees
Market cap
CAD948m
Enterprise valuation
CAD492m (Public information from Sep 2024)
Share price
$20.25 RAPP
Boston Massachusetts (HQ)
Authorizing premium user...